Bibliography

Found 135 results

Filters: Author is Ellis, Ronald J [Clear All Filters]

2006

Chana G, Everall I, Crews LA, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton RK, Ellis RJ, et al. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology [Internet]. 2006 ;67(8):1486-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17060582

Moore D, Masliah E, Rippeth JD, Gonzalez RG, Carey C, Cherner M, Ellis RJ, Achim C, Marcotte TD, Heaton RK, et al. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS (London, England) [Internet]. 2006 ;20(6):879-87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16549972

Pillai SK, Pond SLK, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, et al. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain: A Journal of Neurology [Internet]. 2006 ;129:1872-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16735456

de Almeida SM, Letendre S, Ellis RJ. Human immunodeficiency virus and the central nervous system. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases [Internet]. 2006 ;10:41-50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16767315

Letendre S, Woods SPaul, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I. Lithium improves HIV-associated neurocognitive impairment. AIDS (London, England) [Internet]. 2006 ;20:1885-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16954730

Letendre S, Ellis RJ. Neurologic complications of HIV disease and their treatments. Topics in HIV Medicine: A Publication of the International AIDS Society, USA [Internet]. 2006 ;14:21-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16641524

Langford D, Marquie-Beck J, de Almeida SM, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. Journal of Neurovirology [Internet]. 2006 ;12:100-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16798671

Monteiro de Almeida S, Letendre S, Zimmerman J, Kolakowski S, Lazzaretto D, McCutchan JA, Ellis RJ. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy. Journal of Neuroimmunology [Internet]. 2006 ;179:180-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16901548

2005

Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez RG, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. Journal of NeuroVirology [Internet]. 2005 ;11(4):356-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16206458

Ellis RJ, Evans SR, Clifford DB, Moo LR, McArthur JC, Collier AC, Benson C, Bosch R, Simpson DM, Yiannoutsos CT, et al. Clinical validation of the NeuroScreen. Journal of Neurovirology [Internet]. 2005 ;11(6):503-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16338744

Ellis RJ, Merdes A, Masliah E, Langford TD. Clinical-neuropathological correlation in HIV in the era of highly active antiretroviral therapy. In: Gendelman, H.E.; Grant ELSI ; I ; The Neurology of AIDS. The Neurology of AIDS. London: Oxford University Press; 2005. pp. 799-809.

Monteiro de Almeida S, Letendre S, Zimmerman J, Lazzaretto D, McCutchan JA, Ellis RJ. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. Journal of Neuroimmunology [Internet]. 2005 ;169(1-2):144-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16182380

Letendre S, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte TD, Heaton RK, McCutchan JA, Grant I. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (London, England) [Internet]. 2005 ;19 Suppl 3:S72-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16251831

Jernigan T, Gamst A, Archibald SL, Fennema-Notestine C, Mindt MRivera, Marcotte TD, Heaton RK, Ellis RJ, Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. The American Journal of Psychiatry [Internet]. 2005 ;162(8):1461-72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16055767

Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Good BM, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology [Internet]. 2005 ;79(3):1772-88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15650202

Capparelli EV, Holland D, Okamoto C, Gragg B, Durelle J, Marquie-Beck J, van den Brande G, Ellis RJ, Letendre S. Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV. AIDS (London, England) [Internet]. 2005 ;19(9):949-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15905676

2004

Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen LA, Masliah E. Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. Journal of Neuropathology and Experimental Neurology [Internet]. 2004 ;63(10):1038-47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15535131

Singh K, Ellis RJ, Marquie-Beck J, Letendre S, Heaton RK, Grant I, Spector SA. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. Journal of Neuroimmunology [Internet]. 2004 ;157(1-2):185-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15579296

Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, Ellis RJ, McCutchan JA, Heaton RK, Grant I, Mallory ME, Miller A, et al. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Archives of Neurology [Internet]. 2004 ;61(3):369-76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15023814

Cherner M, Ellis RJ, Lazzaretto D, Young C, Rivera-Mindt M, Atkinson JH, Grant I, Heaton RK, HNRC. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS (London, England) [Internet]. 2004 ;18 Suppl 1:S27-34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15075495

Letendre S, McCutchan JA, Childers ME, Woods SPaul, Lazzaretto D, Heaton RK, Grant I, Ellis RJ, HNRC. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology [Internet]. 2004 ;56:416-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15349869

Marcotte TD, Wolfson TJ, Rosenthal TJ, Heaton RK, Gonzalez RG, Ellis RJ, Grant I, HNRC. A multimodal assessment of driving performance in HIV infection. Neurology [Internet]. 2004 ;63(8):1417-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15505158

2003

Gonzalez RG, Heaton RK, Moore D, Letendre S, Ellis RJ, Wolfson TJ, Marcotte TD, Cherner M, Rippeth JD, Grant I, et al. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. Journal of the International Neuropsychological Society: JINS [Internet]. 2003 ;9(1):64-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12570359

Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, HNRC. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. The Journal of Infectious Diseases [Internet]. 2003 ;188(12):1820-6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14673760

Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E, HNRC. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. Journal of Acquired Immune Deficiency Syndromes (1999) [Internet]. 2003 ;34(5):467-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14657756

Pages